1 September 2022 - A life changing treatment for chronic kidney disease will be made available to thousands of Australians through an expansion of the Pharmaceutical Benefits Scheme (PBS) listing.
The medicine is the first new treatment added to the PBS in more than 20 years for Australians living with proteinuric chronic kidney disease and thousands of Australians could benefit from the subsidised listing each year.